STOCK TITAN

Tenet Healthcare to Sell Five Birmingham Hospitals to Orlando Health

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Tenet Healthcare (NYSE: THC) has announced a definitive agreement to sell its 70% majority ownership in Brookwood Baptist Health in Birmingham to Orlando Health for $910 million in cash. The deal includes five hospitals and related operations, with after-tax proceeds of approximately $790 million. Tenet's Conifer Health Solutions will enter a new 10-year contract for revenue cycle management services. The transaction is expected to complete in fall 2024, subject to regulatory approvals. Tenet estimates a pre-tax book gain of $375 million from this deal. For the twelve months ended June 30, 2024, Tenet's equity interest in Brookwood Baptist Health generated $12 million in pre-tax income and $60 million in Adjusted EBITDA less non-controlling interest. Tenet has reaffirmed its FY24 Adjusted EBITDA Outlook.

Tenet Healthcare (NYSE: THC) ha annunciato un accordo definitivo per vendere la sua partecipazione di maggioranza del 70% in Brookwood Baptist Health a Birmingham a Orlando Health per 910 milioni di dollari in contante. L'affare include cinque ospedali e operazioni correlate, con proventi dopo le tasse di circa 790 milioni di dollari. Le soluzioni Conifer Health di Tenet entreranno in un nuovo contratto decennale per servizi di gestione del ciclo di entrate. Si prevede che la transazione si completi nell'autunno del 2024, soggetta ad approvazioni regolatorie. Tenet stima un guadagno contabile ante imposte di 375 milioni di dollari da questo affare. Nei dodici mesi terminati il 30 giugno 2024, l'interesse patrimoniale di Tenet in Brookwood Baptist Health ha generato 12 milioni di dollari di reddito ante imposte e 60 milioni di dollari di EBITDA rettificato al netto dell'interesse non controllante. Tenet ha confermato le sue previsioni di EBITDA rettificato per l'anno fiscale 2024.

Tenet Healthcare (NYSE: THC) ha anunciado un acuerdo definitivo para vender su participación mayoritaria del 70% en Brookwood Baptist Health en Birmingham a Orlando Health por 910 millones de dólares en efectivo. El acuerdo incluye cinco hospitales y operaciones relacionadas, con ingresos netos después de impuestos de aproximadamente 790 millones de dólares. Conifer Health Solutions de Tenet firmará un nuevo contrato de 10 años para servicios de gestión del ciclo de ingresos. Se espera que la transacción se complete en otoño de 2024, sujeta a aprobaciones regulatorias. Tenet estima una ganancia contable antes de impuestos de 375 millones de dólares por este acuerdo. Durante los doce meses finalizados el 30 de junio de 2024, el interés patrimonial de Tenet en Brookwood Baptist Health generó 12 millones de dólares de ingresos antes de impuestos y 60 millones de dólares de EBITDA ajustado menos el interés no controlante. Tenet ha reafirmado sus previsiones de EBITDA ajustado para el año fiscal 2024.

테넷 헬스케어 (NYSE: THC)가 브룩우드 밥티스트 헬스의 70%의 지배권을 올란도 헬스에 9억 1천만 달러 현금으로 판매하기 위한 확정 계약을 발표했습니다. 이 거래에는 5개의 병원과 관련 운영이 포함되며, 세후 수익은 약 7억 9천만 달러입니다. 테넷의 코니퍼 헬스 솔루션은 수익 주기 관리 서비스에 대해 10년 계약을 체결할 것입니다. 이 거래는 규제 승인에 따라 2024년 가을에 완료될 것으로 예상됩니다. 테넷은 이번 거래로 세전 장부 이익 3억 7천5백만 달러를 추정하고 있습니다. 2024년 6월 30일 종료된 12개월 동안, 테넷의 브룩우드 밥티스트 헬스에 대한 지분이 세전 수익 1천2백만 달러조정 EBITDA 6천만 달러를 생성했습니다. 테넷은 FY24 조정 EBITDA 전망을 재확인했습니다.

Tenet Healthcare (NYSE: THC) a annoncé un accord définitif pour vendre sa participation majoritaire de 70 % dans Brookwood Baptist Health à Birmingham à Orlando Health pour 910 millions de dollars en espèces. L'accord comprend cinq hôpitaux et des opérations connexes, avec des produits après impôts d'environ 790 millions de dollars. Les Solutions Conifer Health de Tenet entreront dans un nouveau contrat de 10 ans pour des services de gestion du cycle de revenus. La transaction devrait être finalisée à l'automne 2024, sous réserve des approbations réglementaires. Tenet estime un gain comptable avant impôts de 375 millions de dollars grâce à cet accord. Pour les douze mois se terminant le 30 juin 2024, l'intérêt de Tenet dans Brookwood Baptist Health a généré 12 millions de dollars de revenus avant impôts et 60 millions de dollars d'EBITDA ajusté après déduction des intérêts non contrôlants. Tenet a réaffirmé ses prévisions d'EBITDA ajusté pour l'exercice 2024.

Tenet Healthcare (NYSE: THC) hat eine bindende Vereinbarung bekannt gegeben, um seinen 70% -Mehrheitsanteil an Brookwood Baptist Health in Birmingham für 910 Millionen Dollar in bar an Orlando Health zu verkaufen. Der Deal umfasst fünf Krankenhäuser und zugehörige Betriebe, mit nach Steuern geschätzten Erlösen von ungefähr 790 Millionen Dollar. Tenets Conifer Health Solutions wird einen neuen 10-Jahres-Vertrag für Dienstleistungen zum Management des Erlöszyklus abschließen. Die Transaktion soll im Herbst 2024 abgeschlossen werden, vorbehaltlich behördlicher Genehmigungen. Tenet schätzt einen steuerfreien Buchgewinn von 375 Millionen Dollar aus diesem Deal. Im Zeitraum von zwölf Monaten bis zum 30. Juni 2024 erzielte Tenets Eigenkapitalanteil an Brookwood Baptist Health 12 Millionen Dollar Vorsteuerertrag und 60 Millionen Dollar bereinigtes EBITDA abzüglich nicht beherrschender Anteile. Tenet hat seine Prognose für das bereinigte EBITDA für das Geschäftsjahr 2024 bestätigt.

Positive
  • Sale of 70% ownership in Brookwood Baptist Health for $910 million in cash
  • After-tax proceeds of approximately $790 million
  • New 10-year contract for Conifer Health Solutions
  • Estimated pre-tax book gain of $375 million
  • Reaffirmation of FY24 Adjusted EBITDA Outlook
Negative
  • Divestiture of five hospitals and related operations in Birmingham
  • Loss of $12 million in annual pre-tax income from the sold assets
  • Reduction of $60 million in annual Adjusted EBITDA less non-controlling interest

This $910 million sale of Tenet's Birmingham hospitals is a significant divestiture, potentially reshaping Tenet's portfolio. The $790 million after-tax proceeds could strengthen Tenet's balance sheet or fund strategic initiatives. However, the loss of $60 million in annual Adjusted EBITDA might impact future earnings. The new 10-year contract with Conifer Health Solutions for revenue cycle management services partially offsets this, providing a stable revenue stream. The estimated pre-tax book gain of $375 million will likely boost Tenet's financial results in the quarter of the sale's completion. Importantly, Tenet's reaffirmation of its FY24 Adjusted EBITDA outlook suggests this divestiture aligns with their financial strategy, potentially indicating more focus on higher-margin operations.

This divestiture reflects a strategic shift in Tenet's portfolio management. By selling majority ownership in these Birmingham hospitals, Tenet is likely streamlining operations and focusing on more profitable markets. The deal with Orlando Health, a reputable non-profit system, ensures continuity of care for the Birmingham community. The retention of the joint venture structure with Baptist Health System demonstrates Tenet's commitment to partnership models. This move could allow Tenet to reallocate resources to higher-growth areas or emerging healthcare trends. The expanded contract for Conifer Health Solutions highlights Tenet's strategy to grow its high-margin services segment, potentially offsetting the loss of direct hospital revenues.

This transaction signals a broader trend in the healthcare industry towards regional consolidation and specialization. Orlando Health's expansion into Alabama indicates their growth strategy and could reshape the competitive landscape in the Southeast. For Tenet, this move might be part of a larger portfolio optimization strategy, potentially leading to similar divestitures in other markets. The deal's structure, maintaining a joint venture and securing a long-term service contract, reflects a nuanced approach to market exit. Investors should watch for potential follow-on effects in the regional healthcare market, including possible responses from competitors or further consolidation moves. This transaction could also signal Tenet's increased focus on its Conifer Health Solutions subsidiary as a growth driver.

Tenet announces agreement to sell Birmingham hospitals and related operations; reaffirms latest FY24 Adjusted EBITDA Outlook

DALLAS--(BUSINESS WIRE)-- Tenet Healthcare Corporation (NYSE: THC) has entered into a definitive agreement with Orlando Health for the sale of Tenet’s 70% majority ownership interest in Brookwood Baptist Health in Birmingham for approximately $910 million in cash (after-tax proceeds of approximately $790 million).

The transaction will include five hospitals – Brookwood Baptist Medical Center, Princeton Baptist Medical Center, Walker Baptist Medical Center, Shelby Baptist Medical Center, Citizens Baptist Medical Center – as well as affiliated physician practices and other related operations. Brookwood Baptist Health will remain a joint venture with Baptist Health System.

Additionally, under the agreement, Tenet’s Conifer Health Solutions subsidiary will enter into a new and expanded ten-year contract to provide revenue cycle management services for the Birmingham hospitals and related operations.

“We are grateful for the partnership with Baptist Health System, which has enabled us to collectively enhance the high-quality, compassionate care that Brookwood Baptist Health offers,” said Saum Sutaria, M.D., Chairman and CEO, Tenet Healthcare. “Orlando Health is an esteemed, high-performing healthcare organization with an over century-long commitment to improving the health and wellness of the communities they serve. Integration of these hospitals into their network will advance healthcare for the greater Birmingham communities.”

For the twelve months ended June 30, 2024, Tenet’s equity interest in the Brookwood Baptist Health joint venture generated pre-tax income of approximately $12 million and an Adjusted EBITDA less non-controlling interest of approximately $60 million, excluding interest expense of approximately $2 million and depreciation and amortization expense of approximately $46 million. The company estimates recording a pre-tax book gain of approximately $375 million as a result of this anticipated transaction.

The transaction is expected to be completed in the fall of 2024, subject to customary regulatory approvals, clearances, and closing conditions.

Tenet also reaffirmed its latest FY24 Adjusted EBITDA Outlook range included in its second quarter 2024 earnings release.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

Cautionary Statement

This release contains “forward-looking statements” - that is, statements that relate to future, not past, events. In this context, forward-looking statements often address the Company’s expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “assume,” “believe,” “budget,” “estimate,” “forecast,” “intend,” “plan,” “predict,” “project,” “seek,” “see,” “target,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause the Company’s actual results to be materially different than those expressed in the Company’s forward-looking statements include but are not limited to the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2023, and other filings with the Securities and Exchange Commission.

Investor Contact

Will McDowell

469-893-2387

William.McDowell@tenethealth.com

Media Contact

Robert Dyer

469-893-2640

mediarelations@tenethealth.com

Source: Tenet Healthcare Corporation

FAQ

What is the value of Tenet Healthcare's sale of Birmingham hospitals to Orlando Health?

Tenet Healthcare (THC) is selling its 70% majority ownership in Brookwood Baptist Health in Birmingham to Orlando Health for $910 million in cash, with after-tax proceeds of approximately $790 million.

How many hospitals is Tenet Healthcare (THC) selling in Birmingham?

Tenet Healthcare is selling five hospitals in Birmingham as part of the Brookwood Baptist Health deal with Orlando Health.

When is the Tenet Healthcare (THC) Birmingham hospital sale expected to close?

The transaction between Tenet Healthcare and Orlando Health is expected to be completed in the fall of 2024, subject to customary regulatory approvals and closing conditions.

What is the estimated financial impact of the Birmingham hospital sale on Tenet Healthcare (THC)?

Tenet Healthcare estimates recording a pre-tax book gain of approximately $375 million as a result of this transaction. The sold assets generated $12 million in pre-tax income and $60 million in Adjusted EBITDA less non-controlling interest for the twelve months ended June 30, 2024.

Tenet Healthcare Corporation New

NYSE:THC

THC Rankings

THC Latest News

THC Stock Data

15.33B
97.68M
1.16%
98.69%
3.44%
Medical Care Facilities
Pharmaceutical Preparations
Link
United States of America
CHAPEL HILL